The growing geriatric population bodes well for the vasculitis therapy market.
According to Vasculitis Treatment Market, the incidence of occurrence of vasculitis often increases in the 50s; nevertheless, newborns and young individuals can also be affected. In 2014, 46.2 million persons in the United States were over the age of 65, according to the Administration for Community Living. It is anticipated that by 2060, there will be approximately 98 million persons in this age bracket. Furthermore, recent technological advancements have resulted in a huge increase in global life expectancy. As the senior population grows, so does the likelihood of vasculitis. As patients have grown more health-conscious and healthcare spending has risen dramatically.
Source Link @ https://www.coherentmarketinsights.com/market-insight/vasculitis-treatment-market-150
